CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan

Stock Information for CytoSorbents Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CytoSorbents Corporation

CytoSorbents Secures $20 Million Credit Facility
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi(TM) Blood Pump in the European Union
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
CytoSorbents Reports First Quarter 2024 Results
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.